Zenotech Laboratories Ltd

Zenotech Laboratories Ltd

$ZENOTECHPharmaceuticalsBSE

Zenotech Laboratories Ltd (ZENOTECH) last traded at ₹45, a market capitalisation of ₹275 crore. Over the past 52 weeks the stock has ranged between ₹33.6 and ₹57.9. Zenotech Laboratories Ltd last reported results for the quarter ended Sep 2006, with sales of ₹5.27 crore and net profit of ₹0.73 crore. Zenotech Laboratories Ltd’s annual general meeting is scheduled for 25 Sept 2026. Figures are as of 25 Aug 2026 and are not real time.

Zenotech Laboratories Ltd share price and key metrics

Current price
₹45
Market cap
₹275 cr
Book value
₹15.8
ROE
-12.2%
ROCE
-9.08%
Dividend yield
0.00%
52w high / low
57.9/33.6

Metrics as of 25 Aug 2026. Not real time.

Zenotech Laboratories Ltd quarterly results

Zenotech Laboratories Ltd consolidated quarterly results, figures in ₹ crore
₹ croreJun 2006Sep 2006
Sales2.835.27
Expenses4.33.98
Operating profit-1.471.29
OPM %-51.94%24.48%
Other income0.10.23
Interest0.30.45
Depreciation0.120.34
Profit before tax-1.790.73
Tax %0.00%0.00%
Net profit-1.790.73
EPS (₹)0.14

Consolidated figures as reported by the company. Percentages are as published; totals may not sum exactly.

Zenotech Laboratories Ltd annual results

Zenotech Laboratories Ltd annual profit and loss, figures in ₹ crore
₹ croreMar 2006Mar 2007Mar 2008Mar 2009Mar 2010
Sales1213867
Operating profit-3-6-10-18-9
OPM %-20%-49%-121%-292%-143%
Net profit-42-16-18-13
EPS (₹)0.32-2.64-2.88-2.05

TTM is the trailing twelve months to the most recent quarter.

Zenotech Laboratories Ltd growth and returns

Compounded Sales Growth
10 Years
%
5 Years
%
3 Years
-20%
TTM
9%
Compounded Profit Growth
10 Years
%
5 Years
%
3 Years
%
TTM
29%
Stock Price CAGR
10 Years
2%
5 Years
-4%
3 Years
-5%
1 Year
-18%
Return on Equity
10 Years
%
5 Years
-13%
3 Years
-15%
Last Year
-12%

Zenotech Laboratories Ltd shareholding pattern

Promoters held 68.84% at Jun 2026, broadly unchanged since Jun 2025. DIIs 0.01%.

Zenotech Laboratories Ltd shareholding pattern by quarter, in percent
% heldSep 2024Dec 2024Mar 2025Jun 2025Sep 2025Dec 2025Mar 2026Jun 2026
Promoters68.84%68.84%68.84%68.84%68.84%68.84%68.84%68.84%
DIIs0.01%0.01%0.01%0.01%0.01%0.01%0.01%0.01%
Government0.98%0.98%0.98%0.98%0.98%0.98%0.98%0.98%
Public30.18%30.18%30.18%30.17%30.18%30.18%30.17%30.17%
No. of shareholders10,64110,66710,69010,66110,67010,46410,30110,161

As disclosed by the company to the exchanges. The last row is a count of shareholders, not a percentage.

When is Zenotech Laboratories Ltd’s AGM?

Zenotech Laboratories Ltd’s annual general meeting is scheduled for 25 Sept 2026.

  • AGM37th Annual General Meeting

See the full results calendar for every Indian company reporting in the next 30 days.

Zenotech Laboratories Ltd corporate filings

  • Newspaper AdvertisementCompany Updatelow impact
    Filing PDF

    Cruxal's analysis: Zenotech Laboratories Ltd has fulfilled its regulatory obligation under Regulation 30 of…

    Read the full analysis
  • Intimation of 37th Annual General Meeting of the Company to be held on Friday, September 25, 2026 at 10:30 a.m. IST through Video Conferencing mode.AGM/EGMlow impact
    Filing PDF

    Cruxal's analysis: Zenotech Laboratories Limited has formally announced that its 37th Annual General Meeting…

    Read the full analysis

This page shows filings on a one-hour delay. Sign in to see them as they land, with Cruxal's analysis of what each one means.

Track Zenotech Laboratories Ltd

Cruxal reads every Zenotech Laboratories Ltd filing as it lands, scores what it means for the stock, and emails you the ones that matter. Free to start.

Cruxal publishes market data and coverage for information only. Nothing here is investment advice.

Zenotech Laboratories Ltd (ZENOTECH) Results, Financials & Share Price | Cruxal